Ticker > Company >

Neochem Bio Solution share price

Neochem Bio Solutions Ltd.

NSE: NEOCHEM SECTOR: Chemicals  43   0   0

109.60
-2.20 (-1.97%)
NSE: 10 Dec 4:00 PM

Price Summary

Today's High

₹ 113

Today's Low

₹ 106.25

52 Week High

₹ 113.4

52 Week Low

₹ 102.6

FinStar

Ownership Below Par
Stock price may face volatility due to ownership structure.
ValuationAttractive
The stock is considerably attractive based on intrinsic value.
EfficiencyOptimal
The company could improve upon its asset employment.
FinancialsWeak
Watch out! The company might not be able to sustain any adverse condition.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

187.64 Cr.

Enterprise Value

220.62 Cr.

No. of Shares

1.71 Cr.

P/E

97.37

P/B

0

Face Value

₹ 10

Div. Yield

0 %

Book Value (TTM)

₹  0

CASH

0.35 Cr.

DEBT

33.32 Cr.

Promoter Holding

-

EPS (TTM)

₹  1.13

Sales Growth

26.89%

ROE

18.62 %

ROCE

14.38%

Profit Growth

68.94 %

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.
* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year26.89%
3 YearNA
5 YearNA

Profit Growth

1 Year68.94%
3 YearNA
5 YearNA

ROE%

1 Year18.62%
3 Year20.21%

ROCE %

1 Year14.38%
3 Year11.88%

Debt/Equity

2.7065

Price to Cash Flow

-297.32

Interest Cover Ratio

1.9478

CFO/PAT (5 Yr. Avg.)

0

Shareholding Pattern

Investors List
 Share Holding Data is not available for this company.Report us
* Figures given above are % of equity capital

 Strengths

  • Company has been maintaining healthy ROE of 20.2131% over the past 3 years.
  • The company has an efficient Cash Conversion Cycle of 60.9248 days.

 Limitations

  • The company has shown a poor profit growth of 0% for the Past 3 years.
  • The company has shown a poor revenue growth of 0% for the Past 3 years.
  • Company has negative cash flow from operations of -0.6311261.
  • The company has a low EBITDA margin of 0% over the past 5 years.
  • The company is trading at a high EV/EBITDA of 31.5886.

Quarterly Result (All Figures in Cr.)

 Quarterly Data is not available for this company.Report us

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2022 Mar 2023 Mar 2024
Net Sales 48.6 48.19 61.15
Total Expenditure 45.08 43.89 55.02
Operating Profit 3.51 4.29 6.12
Other Income 0.09 0.6 0.86
Interest 1.28 2.1 2.96
Depreciation 1.04 1.22 1.22
Exceptional Items 0 0 0
Profit Before Tax 1.28 1.59 2.8
Tax 0.31 0.45 0.88
Net Profit 0.97 1.14 1.93
Adjusted EPS (Rs.) 1.85 1.2 1.65

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2022 Mar 2023 Mar 2024
Equity and Liabilities
Share Capital 3 5.43 6.68
Total Reserves 1.09 2.96 5.64
Borrowings 15.1 12.33 18.12
Other N/C liabilities 0.72 0.74 0.74
Current liabilities 26.47 29.21 32.29
Total Liabilities 46.38 50.67 63.46
Assets
Net Block 12.44 14.67 18.81
Capital WIP 0.15 0.04 0.03
Intangible WIP 0 0 0
Investments 0.09 0.09 0
Loans & Advances 0.79 0.35 3.33
Other N/C Assets 3.79 3.79 3.7
Current Assets 29.12 31.72 37.59
Total Assets 46.38 50.67 63.46
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2022 Mar 2023 Mar 2024
Profit from operations 0.97 1.14 1.93
Adjustment 2.3 3.32 4.19
Changes in Assets & Liabilities -4.53 -5.43 -6.74
Tax Paid -0.2 0 0
Operating Cash Flow -1.46 -0.97 -0.63
Investing Cash Flow -2.74 -3.32 -5.26
Financing Cash Flow 4.33 3.95 6.2
Net Cash Flow 0.12 -0.34 0.3

Corporate Actions

Investors Details

 No Promoters Data available for this company.Report us
 No Investors Data available for this company.Report us

Annual Reports

Title Link
Title Link
 No Annual reports exist for this company.Report us

Ratings & Research Reports

TYPE AGENCY Link
TYPE AGENCY Link
 No Credit and Research reports exist for this company.Report us
TYPE AGENCY Link
TYPE AGENCY Link
 No Research reports exist for this company.Report us

Concalls & Presentations

TYPE QUARTER Link
TYPE QUARTER Link
 Currently we do not have any Presentation and Concall related to this company.Report us
TYPE QUARTER Link
TYPE QUARTER Link
 Currently we do not have any Presentation related to this company.Report us

Neochem Bio Solution Stock Price Analysis and Quick Research Report. Is Neochem Bio Solution an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Neochem Bio Solution. 

  • PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Neochem Bio Solution has a PE ratio of 97.3702914001422 which is high and comparatively overvalued.

  • Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Neochem Bio Solution has ROA of 3.3771% which is a bad sign for future performance. (Higher values are always desirable.)

  • Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Neochem Bio Solution has a Current ratio of 1.1641.

  • Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Neochem Bio Solution has a ROE of 18.6208%. (Higher is better)

  • Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. Neochem Bio Solution has a Debt to Equity ratio of 2.7065 which means that the company has high proportion of debt in its capital.

  • Sales growth: Neochem Bio Solution has reported revenue growth of 26.8904% which is fair in relation to its growth and performance. 

  • Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of Neochem Bio Solution for the current financial year is 10.0133529892683%.

  • Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Neochem Bio Solution is Rs 0 and the yield is 0%.

  • Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Neochem Bio Solution is Rs 1.1256. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Neochem Bio Solution in Ticker for free. Also, one can get the intrinsic value of Neochem Bio Solution by using Valuation Calculators, which are available with a Finology ONE subscription. 

Neochem Bio Solution FAQs

Q1. What is Neochem Bio Solution share price today?
Ans: The current share price of Neochem Bio Solution is Rs 109.6.

Q2. What is the market capitalisation of Neochem Bio Solution?
Ans: Neochem Bio Solution has a market capitalisation of Rs 187.64345288 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of Neochem Bio Solution?
Ans: The PE ratio of Neochem Bio Solution is 97.3702914001422 and the P/B ratio of Neochem Bio Solution is 0, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of Neochem Bio Solution share?
Ans: The 52-week high share price of Neochem Bio Solution is Rs 113.4, and the 52-week low share price of Neochem Bio Solution is Rs 102.6.

Q5. Does Neochem Bio Solution pay dividends?
Ans: Currently, Neochem Bio Solution does not pay dividends. Dividend yield of Neochem Bio Solution is around 0%.

Q6. What are the face value and book value of Neochem Bio Solution shares?
Ans: The face value of Neochem Bio Solution shares is Rs 10, while the book value per share of Neochem Bio Solution is around Rs 0. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of Neochem Bio Solution?
Ans: Neochem Bio Solution has a total debt of Rs 33.3234648 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of Neochem Bio Solution?
Ans: The ROE of Neochem Bio Solution is 18.6208% and ROCE of Neochem Bio Solution is 14.3777%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is Neochem Bio Solution a good buy for the long term?
Ans: The Neochem Bio Solution long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is Neochem Bio Solution undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the Neochem Bio Solution appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check Neochem Bio Solution’s financials?
Ans: You can review Neochem Bio Solution’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.

Last Updated on:
Brief about Neochem Bio Solution
X